Integrated Research Limited

As of June 30, 2024, Integrated Research Limited carries a market capitalization of 162.39M, placing it among publicly traded companies globally. Its enterprise value stands at 131.10M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Integrated Research Limited's next confirmed earnings release is scheduled for February 24, 2027.

As of June 30, 2024, Integrated Research Limited has 174.61M shares outstanding.

As of June 30, 2024, Integrated Research Limited trades at a trailing price-to-earnings ratio of 5.97. The price-to-sales ratio is 1.95, and the price-to-book ratio stands at 1.84.

As of June 30, 2024, Integrated Research Limited trades at an EV/EBITDA multiple of 5.17 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.57 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 5.20 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 131.10M versus a market cap of 162.39M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2024, Integrated Research Limited maintains a current ratio of 3.12, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2024, Integrated Research Limited posted a return on equity (ROE) of 36.60, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 26.61, measuring how efficiently the asset base is converted into earnings. The company generates approximately 586,563.38 in revenue per employee across its workforce of 142.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2024, Integrated Research Limited recorded an income tax benefit of -416,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 26.71M, leaving 27.13M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Integrated Research Limited's stock has declined approximately 23.29% over the past 52 weeks. The 50-day moving average sits at 0.29, while the 200-day moving average is 0.30.

Over the twelve months ended June 30, 2024, Integrated Research Limited generated 83.29M in revenue and converted that into 27.13M in net income, yielding earnings per share of 0.16. EBITDA reached 25.34M, while operating income came in at 25.23M.

As of June 30, 2024, Integrated Research Limited holds 33.00M in cash and equivalents against 1.72M in total debt, resulting in a net debt position of -31.89M. Total book value stands at 88.36M, with working capital of 52.97M providing operational flexibility.

These figures cover the twelve months ended June 30, 2024.

These figures cover the twelve months ended June 30, 2024. The operating margin of 30.29 and net profit margin of 32.57 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2024. Total shareholder yield reaches 1.04, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Integrated Research Limited shareholders.

As of June 30, 2024, Integrated Research Limited has an Altman Z-Score of 6.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.